DS Stage II Plasma Cell Myeloma
Showing 1 - 12 of 12
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Jacksonville,
Completed
- DS Stage I Plasma Cell Myeloma
- +3 more
- Autologous Bone Marrow Transplantation
- +4 more
-
Jacksonville, Florida
- +1 more
Aug 18, 2020
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in New Brunswick, Bronx,
Completed
- DS Stage I Plasma Cell Myeloma
- +3 more
- Busulfan
- +4 more
-
New Brunswick, New Jersey
- +3 more
Aug 11, 2020
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Bronx (drug,
Completed
- DS Stage I Plasma Cell Myeloma
- +3 more
- Desipramine Hydrochloride
- +2 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Dec 10, 2019
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Seattle
Completed
- DS Stage I Plasma Cell Myeloma
- +3 more
- Clarithromycin
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Oct 29, 2019
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in United States
Completed
- DS Stage I Plasma Cell Myeloma
- +2 more
- Bortezomib
- +2 more
-
Mountain View, California
- +24 more
Sep 20, 2019
Breast Adenocarcinoma, DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma Trial in Puerto Rico, United States
Completed
- Breast Adenocarcinoma
- +6 more
- zoledronic acid
-
Fairbanks, Alaska
- +503 more
Oct 8, 2018
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Rochester (drug,
Completed
- DS Stage I Plasma Cell Myeloma
- +3 more
- Bortezomib
- +6 more
-
Rochester, MinnesotaMayo Clinic
May 23, 2018
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Tampa (procedure,
Withdrawn
- DS Stage I Plasma Cell Myeloma
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +5 more
-
Tampa, FloridaMoffitt Cancer Center
Sep 27, 2017
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Seattle (Bortezomib,
Completed
- DS Stage I Plasma Cell Myeloma
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 1, 2017
DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Bronx (Romidepsin,
Completed
- DS Stage II Plasma Cell Myeloma
- +2 more
- Romidepsin
- Laboratory Biomarker Analysis
-
Bronx, New YorkMontefiore Medical Center - Moses Campus
Mar 16, 2015
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Baltimore
Completed
- DS Stage I Plasma Cell Myeloma
- +3 more
- Vismodegib
- +2 more
-
Baltimore, Maryland
- +1 more
Dec 19, 2014